Tirzepatide after weight loss surgery
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether giving tirzepatide (a medicine that helps with weight and blood sugar) right after weight loss surgery can improve results. It is for people who are already scheduled for sleeve gastrectomy or gastric bypass at UK HealthCare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already enrolled in the UK HealthCare weight loss surgery program and are scheduled for a sleeve gastrectomy or gastric bypass.
- You have a BMI of 40 or higher and at least one obesity-related health problem (like diabetes, high blood pressure, or sleep apnea).
- You have stopped using nicotine (cigarettes, vaping, etc.) and can prove it with a blood test.
- You are enrolled in the ADORE Bariatric Tissue Bank study.
- You have not used any GLP-1 medicines (like Ozempic, Wegovy, or Mounjaro) in the last 90 days.
- You do not have certain medical conditions, including a personal or family history of medullary thyroid cancer, pancreatitis, or type 1 diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study tests whether tirzepatide, a medication that helps with weight loss and blood sugar control, can improve the ability to exercise and daily function in people who have heart failure with reduced pumping strength and are overweight or obese.
This study tests a weekly injection called tirzepatide to help people with obesity lose weight. It will be done at Hospital de Clínicas in Paraguay and lasts about 12 months.
This study tests a new medication called tirzepatide, given at carefully adjusted doses, to help people with obesity lose weight while reducing unwanted side effects. Tirzepatide is a newer injectable medicine that helps control appetite and blood sugar.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
Hear when a new Obesity and Obesity-related Medical Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.